BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1318 related articles for article (PubMed ID: 19762681)

  • 1. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
    Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
    Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MyD88 signaling controls autoimmune myocarditis induction.
    Marty RR; Dirnhofer S; Mauermann N; Schweikert S; Akira S; Hunziker L; Penninger JM; Eriksson U
    Circulation; 2006 Jan; 113(2):258-65. PubMed ID: 16401773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis.
    Kania G; Blyszczuk P; Stein S; Valaperti A; Germano D; Dirnhofer S; Hunziker L; Matter CM; Eriksson U
    Circ Res; 2009 Aug; 105(5):462-70. PubMed ID: 19628793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis.
    Pagni PP; Traub S; Demaria O; Chasson L; Alexopoulou L
    Autoimmunity; 2010 Jun; 43(4):275-87. PubMed ID: 20187710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.
    Baldeviano GC; Barin JG; Talor MV; Srinivasan S; Bedja D; Zheng D; Gabrielson K; Iwakura Y; Rose NR; Cihakova D
    Circ Res; 2010 May; 106(10):1646-55. PubMed ID: 20378858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis.
    Kania G; Blyszczuk P; Valaperti A; Dieterle T; Leimenstoll B; Dirnhofer S; Zulewski H; Eriksson U
    Cardiovasc Res; 2008 Nov; 80(2):236-45. PubMed ID: 18621802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of cardiac fibrosis in inflammatory heart disease.
    Kania G; Blyszczuk P; Eriksson U
    Trends Cardiovasc Med; 2009 Nov; 19(8):247-52. PubMed ID: 20447565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
    Fuse K; Chan G; Liu Y; Gudgeon P; Husain M; Chen M; Yeh WC; Akira S; Liu PP
    Circulation; 2005 Oct; 112(15):2276-85. PubMed ID: 16216974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis.
    Kania G; Siegert S; Behnke S; Prados-Rosales R; Casadevall A; Lüscher TF; Luther SA; Kopf M; Eriksson U; Blyszczuk P
    Circulation; 2013 Jun; 127(23):2285-94. PubMed ID: 23671208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity.
    Eriksson U; Ricci R; Hunziker L; Kurrer MO; Oudit GY; Watts TH; Sonderegger I; Bachmaier K; Kopf M; Penninger JM
    Nat Med; 2003 Dec; 9(12):1484-90. PubMed ID: 14625544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells and autoimmune heart failure.
    Marty RR; Eriksson U
    Int J Cardiol; 2006 Sep; 112(1):34-9. PubMed ID: 16891018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD69 limits the severity of cardiomyopathy after autoimmune myocarditis.
    Cruz-Adalia A; Jiménez-Borreguero LJ; Ramírez-Huesca M; Chico-Calero I; Barreiro O; López-Conesa E; Fresno M; Sánchez-Madrid F; Martín P
    Circulation; 2010 Oct; 122(14):1396-404. PubMed ID: 20855659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
    Wang Z; Liao Y; Dong J; Li S; Wang J; Fu ML
    Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis.
    Blyszczuk P; Behnke S; Lüscher TF; Eriksson U; Kania G
    Biochim Biophys Acta; 2013 Apr; 1833(4):934-44. PubMed ID: 23103516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Sema4A in the progression of experimental autoimmune myocarditis.
    Makino N; Toyofuku T; Takegahara N; Takamatsu H; Okuno T; Nakagawa Y; Kang S; Nojima S; Hori M; Kikutani H; Kumanogoh A
    FEBS Lett; 2008 Nov; 582(28):3935-40. PubMed ID: 18977352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17.
    Rangachari M; Mauermann N; Marty RR; Dirnhofer S; Kurrer MO; Komnenovic V; Penninger JM; Eriksson U
    J Exp Med; 2006 Aug; 203(8):2009-19. PubMed ID: 16880257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice.
    Gangaplara A; Massilamany C; Brown DM; Delhon G; Pattnaik AK; Chapman N; Rose N; Steffen D; Reddy J
    Clin Immunol; 2012 Sep; 144(3):237-49. PubMed ID: 22854287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in cardiac function and gene expression during autoimmune myocarditis in mice.
    Stull LB; DiIulio NA; Yu M; McTiernan CF; Ratliff NB; Tuohy VK; Moravec CS
    J Mol Cell Cardiol; 2000 Nov; 32(11):2035-49. PubMed ID: 11040107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
    Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML
    J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.